SCHEMBL24178578

SCHEMBL24178578

Bc1c(B)c(B)c(-c2c3ccccc3c(-c3cc(-c4ccccc4)c4ccccc4c3)c3ccccc23)c(B)c1B

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ MPI P34949 1/20 0.49
▸ HSD17B1 P14061 1/20 0.39
▸ HSD17B2 P37059 1/20 0.39
▸ GPR84 Q9NQS5 4/20 0.38
▸ RECQL P46063 1/20 0.36
▸ ESR1 P03372 3/20 0.36
▸ ESR2 Q92731 3/20 0.36
▸ CYP11B1 P15538 1/20 0.35
▸ ALOX5 P09917 2/20 0.34
▸ MAPK1 P28482 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ PTGES O14684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25638131 0.91 MEN1 (0.51) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL24925978 0.89 MEN1 (0.49) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL22694833 0.87 MEN1 (0.41) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL25492997 0.84 MEN1 (0.39) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL21870276 0.84 MEN1 (0.49) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL25508789 0.80 HSD17B1 (0.42) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL23073582 0.79 MEN1 (0.37) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL25638105 0.79 MEN1 (0.44) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL25633653 0.78 MCL1 (0.36) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL24178697 0.77 SOS1 (0.36) MEN1KMT2AKDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200099-A1 ORGANIC LIGHT-EMITTING DIODE WITH HIGH EFFICIENCY AND LONG LIFESPAN SFC CO., LTD. (KR) 2023-06-22 — — US disclosed
US-20230165032-A1 ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC DERIVATIVE COMPOUNDS SFC CO., LTD (KR) 2023-05-25 — — US disclosed
US-20230140927-A1 ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS SFC CO., LTD (KR) 2023-05-11 — — US disclosed
US-20220006013-A1 ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS SFC CO., LTD. (KR) 2022-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006013-A1 ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS TYR, DDC, PAH MEN1 2598/4885KMT2A 2114/4885KDM4E 2332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback